Arsenic Trioxide / Trióxido de Arsénico. CAS: 1327-53-3
Product Overview
| Generic Name | Arsenic Trioxide / Trióxido de Arsénico. CAS: 1327-53-3 |
| Brand Name(s) | Trisenox® / Arsenox® |
| Category | Antineoplastic / Cancer |
| Form | Sterile intravenous injection / concentrate for solution for infusion, single-dose vial |
| Strength | 10 mg / 10 mL, 1 mg/mL |
| Therapeutic Class | Arsenical antineoplastic agent; |
| ATC Code | L01XX27 |
Manufacturing & Regulatory
| Manufacturer | Teva / Cephalon, |
| GMP Compliance | WHO-GMP |
| COFEPRIS | 010.000.7098.00 |
| Free Sale Certificate | Request FSC/CPP |
Logistics & Export
| MOQ | Carton of 10 vials |
| Shelf Life | 24 Months |
| Storage | 20°C to 25°C |
| Incoterms | EXW, HS 3004.90 |
| Lead Time | 7 - 10 Business Days |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Supplied per batch upon request |
| SDS-Safety Data Sheet (PDF) | Upon Request, not publicly posted |
| CTD Summary (PDF) | CTD from originator; generic use abbreviated formats |
Special Notes
Arsenic Trioxide is an injectable antineoplastic agent used under specialist supervision for acute promyelocytic leukemia (APL). It is indicated with tretinoin for newly diagnosed low-risk APL and for induction/consolidation in relapsed or refractory APL characterised by t(15;17) translocation or PML/RAR-alpha gene expression.
Packed 10 vials/pack